Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.10 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.286SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.369SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.69SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.87SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.39.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
GA.4.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.3.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.73 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.60 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.124.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GS.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GJ.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XYSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.5.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.2.45SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
GP.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.4.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBQSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.6.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BV.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
GA.4.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GS.7.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.1.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
AD.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.201SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
W.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.560SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.164SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.275SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.258.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.58SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.81SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.419SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.151SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used